Home › Pancreatic Cancer › NCT06388967
Pancreatic Cancer Detection Consortium
RecruitingObservational studyHealthy volunteers welcome
Early Detection of Pancreatic Cancer: Prospective Study
Who can join
Ages 18 and older · All sexes · Healthy volunteers welcome
Full eligibility criteria
Inclusion Criteria: * Histological diagnosis of pancreatic ductal adenocarcinoma, stages I-IV (TNM classification, 8th edition) * Received standard diagnostic and staging procedures as per local guidelines, and at least one sample was drawn before receiving any curative-intent treatment. * Imaging- or endoscopy-based proof of lack of pancreatic ductal adenocarcinoma at the time of sampling (Non-disease controls) Exclusion Criteria: * Lack of written informed consent.
About the study
This study aims to prospective validate an exosome-based miRNA signature for noninvasive and early detection of pancreatic ductal adenocarcinoma.
What is being tested
- PANcreatic cancer Exosome Early detectiON (PANXEON) (diagnostic test)
Sponsor: City of Hope Medical Center · Participants: 2,000 · Started: Mar 15, 2023
Contact the study team
- Ajay Goel, PhD · Phone: 6262183452
Official record on ClinicalTrials.gov — NCT06388967
Locations in the U.S.
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.